Repurposing of some anti-infective drugs for COVID-19 treatment: A surveillance study supported by an in silico investigation
COVID-19 치료를 위한 일부 항감염제의 용도 변경: in silico 조사에 의해 뒷받침되는 감시 연구
Article
[키워드] AAK1
added
Admission
ADP-ribose
anti-infective drug
antimicrobial
Antimicrobials
applied
Azithromycin
binding
binding free energy
binding mode
binding modes
Clinical finding
Clinical findings
clinical outcomes
Combination
Compound
computational studies
Computational study
COVID-19
death
detect
diarrhoea
docked
docking experiment
docking experiments
docking score
doxycycline
drug
effective
Efficacy
enrolled
explain
females
four groups
free energy
Free energy calculations
group
IMPROVE
in silico
in vitro
inhibitors
intensive care
kinase
lead
MDs
Mild
mild to moderate
moderate
Moderate COVID-19
moderate symptoms
molecular
molecular dynamic simulations
nitazoxanide
not seen
outcomes
phosphatase
Protein target
replacement
reported
repurposing
required
Reverse transcription-polymerase chain reaction
ribose
starting point
subject
subjects
supported
Surveillance
Symptom
symptomatic improvement
therapeutic potential
treated
treating COVID-19
Treatment
turn
Viral
[DOI] 10.1111/ijcp.13877 PMC 바로가기 [Article Type] Article
[DOI] 10.1111/ijcp.13877 PMC 바로가기 [Article Type] Article